Compounds > cyanidin-3-o-beta-glucopyranoside

cyanidin-3-o-beta-glucopyranoside and Hypertension--Pulmonary

cyanidin-3-o-beta-glucopyranoside has been researched along with Hypertension--Pulmonary* in 1 studies

Other Studies

1 other study(ies) available for cyanidin-3-o-beta-glucopyranoside and Hypertension--Pulmonary

Article	Year
Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway. Molecular medicine reports, 2021, Volume: 23, Issue:5 Topics: Animals; Anthocyanins; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Monocrotaline; p38 Mitogen-Activated Protein Kinases; Pulmonary Artery; Rats; Transforming Growth Factor beta1; Vascular Remodeling	2021

Article

Year

Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway.

Molecular medicine reports, 2021, Volume: 23, Issue:5

Topics: Animals; Anthocyanins; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Monocrotaline; p38 Mitogen-Activated Protein Kinases; Pulmonary Artery; Rats; Transforming Growth Factor beta1; Vascular Remodeling

2021